Literature DB >> 12791111

Erythropoietin therapy and acute preoperative normovolaemic haemodilution in infants undergoing craniosynostosis surgery.

Luisa Meneghini1, Nicola Zadra, Vittorio Aneloni, Salvatore Metrangolo, Roberto Faggin, Franca Giusti.   

Abstract

BACKGROUND: A retrospective study was performed to evaluate whether pretreatment with erythropoietin and iron combined with acute preoperative normovolaemic haemodilution (APNH) could decrease homologous blood transfusion in craniosynostosis (CS) surgery. A treated group was compared with a historical group of infants who underwent surgery with no pretreatment.
METHODS: The charts of 25 healthy infants who underwent CS surgery were reviewed. Nine of them underwent surgery with no treatment beforehand. Sixteen infants were given erythropoietin at a dosage of 300 U.kg -1 two times per week and iron (elemental iron 10 mg.kg-1.day-1) for 3 weeks before surgery. On the day of surgery APNH was performed after induction of general anaesthesia; a precalculated amount of autologous blood was withdrawn and replaced by hydroxyethyl starch 6%.
RESULTS: Eleven of the 16 infants of the study group received only autologous blood. Five of 16 received homologous blood transfusion vs seven of nine infants in the control group.
CONCLUSIONS: APNH combined with erythropoietin was effective in reducing homologous blood requirements during CS surgery. Further studies are necessary on a larger scale to assess the role of this technique in avoiding homologous blood transfusion and to evaluate how infants can benefit from this combined approach.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791111     DOI: 10.1046/j.1460-9592.2003.01091.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  8 in total

1.  Guideline for Care of Patients With the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis.

Authors:  Irene M J Mathijssen
Journal:  J Craniofac Surg       Date:  2015-09       Impact factor: 1.046

2.  Minimizing blood transfusions in the surgical correction of craniosynostosis: a 10-year single-center experience.

Authors:  Christopher M Bonfield; Julia Sharma; D Douglas Cochrane; Ash Singhal; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2015-09-08       Impact factor: 1.475

3.  Effectiveness of a limited invasive scalp approach in the correction of sagittal craniosynostosis.

Authors:  Luca Massimi; Gianpiero Tamburrini; Massimo Caldarelli; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

4.  Population pharmacokinetics of epsilon-aminocaproic acid in infants undergoing craniofacial reconstruction surgery.

Authors:  P A Stricker; A F Zuppa; J E Fiadjoe; L G Maxwell; E M Sussman; E Y Pruitt; T K Goebel; M R Gastonguay; J A Taylor; S P Bartlett; M S Schreiner
Journal:  Br J Anaesth       Date:  2013-01-25       Impact factor: 9.166

5.  Erythropoietin increases reticulocyte counts and maintains hematocrit in neonates requiring surgery.

Authors:  Ryann Bierer; Mahshid Roohi; Connie Peceny; Robin K Ohls
Journal:  J Pediatr Surg       Date:  2009-08       Impact factor: 2.545

6.  Effect of low dose tranexamic acid on intra-operative blood loss in neurosurgical patients.

Authors:  Ramya Vel; Bidkar Prasanna Udupi; Munaganuri Venkata Siva Satya Prakash; Sethuramachandran Adinarayanan; Sandeep Mishra; Lenin Babu
Journal:  Saudi J Anaesth       Date:  2015-01

7.  Enhanced Recovery Protocol after Fronto-orbital Advancement Reduces Transfusions, Narcotic Usage, and Length of Stay.

Authors:  Rebecca Knackstedt; Niyant Patel
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-10-28

8.  Tranexamic acid to reduce operative blood loss in brain tumor surgery: A meta-analysis.

Authors:  Resi Prastikarunia; Joni Wahyuhadi; Rahadian Indarto Susilo; Irwan Barlian Immadoel Haq
Journal:  Surg Neurol Int       Date:  2021-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.